Professional Seasonal Analysis for Trading

bioAffinity Technologies, Inc. - Common Stock (BIAF)

Seasonality Analysis

Stocks 4 Years Analyzed

bioAffinity Technologies, Inc. - Common Stock Annual Seasonality Statistics

-47.59%
Avg Annual Return
29.9%
Avg Monthly Win Rate
4/12
Positive Months
4
Years Analyzed

bioAffinity Technologies, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 8.63%
25%
Weak
February -7.52%
25%
Very Weak
March BEST 58.70%
50%
Weak
April -12.32%
50%
Weak
May -17.94%
0%
Very Weak
June 0.27%
67%
Moderate
July 8.45%
67%
Strong
August -20.55%
0%
Very Weak
September WORST -27.25%
25%
Very Weak
October -10.92%
25%
Very Weak
November -5.00%
25%
Very Weak
December -22.13%
0%
Very Weak

bioAffinity Technologies, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
52.5
Historical Avg Position
50.84
Deviation
+1.66
Performance
On Track

bioAffinity Technologies, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for BIAF with overlay patterns, custom date ranges, and more.

Create Free Account

bioAffinity Technologies, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

bioAffinity Technologies, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for BIAF across multiple timeframes.

Create Free Account

About bioAffinity Technologies, Inc. - Common Stock (BIAF) Seasonality

bioAffinity Technologies, Inc. - Common Stock (BIAF) has been analyzed using 4 years of historical data to identify seasonal patterns. Classified under Stocks, bioAffinity Technologies, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for bioAffinity Technologies, Inc. - Common Stock is historically March, with an average return of 58.70% and a win rate of 50%. Conversely, September tends to be the weakest month, averaging -27.25% return.

Looking at the full calendar year, bioAffinity Technologies, Inc. - Common Stock has an average annual return of -47.59% with an overall monthly win rate of 29.9%. Out of 12 months, 4 typically show positive average returns.

The seasonal pattern for bioAffinity Technologies, Inc. - Common Stock has a consistency score of 72.5 (Very Good), based on 5 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

bioAffinity Technologies, Inc. - Common Stock Seasonality FAQ

What is the best month to buy bioAffinity Technologies, Inc. - Common Stock (BIAF)?

Historically, March has been the best month for bioAffinity Technologies, Inc. - Common Stock, with an average return of 58.70% and a win rate of 50%. However, past performance does not guarantee future results.

What is the worst month for bioAffinity Technologies, Inc. - Common Stock (BIAF)?

Based on historical data, September has been the weakest month for bioAffinity Technologies, Inc. - Common Stock, with an average return of -27.25%. This is a historical observation and does not guarantee future results.

How reliable is BIAF seasonality data?

The seasonality analysis for bioAffinity Technologies, Inc. - Common Stock is based on 4 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use bioAffinity Technologies, Inc. - Common Stock seasonality in my trading?

Use bioAffinity Technologies, Inc. - Common Stock (BIAF) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.